MicroPort MedBot recently announced that the DFVision™ 3D Fluorescence Electronic Endoscope, a key imaging component of the Toumai® Multi-Port Robotic Surgical System, has received EU CE certification under the Medical Device Regulation (MDR).

This milestone marks another major recognition of China’s independent innovation in the global surgical robotics field and paves the way for Toumai’s further expansion into European and other international high-end markets.

Enhanced Intraoperative Visualization for Precision Surgery

The newly certified fluorescence imaging system integrates cutting-edge optics and intelligent image fusion to support complex, multidisciplinary procedures. Using indocyanine green (ICG) as a contrast agent, the system combines visible and near-infrared light capture with a proprietary dynamic fusion gain algorithm, allowing surgeons to visualize tumor boundaries, vascular structures, and tissue perfusion in real time.

Unlike traditional white-light imaging, which shows only anatomical surfaces, the Toumai® fluorescence system offers functional insights at the molecular and perfusion level, helping surgeons accurately distinguish malignant from healthy tissue and detect small residual lesions during oncologic or reconstructive procedures.

Eight Fluorescence Display Modes, Seamless Real-Time Switching

With eight switchable fluorescence display modes, the system enables real-time visualization of both fluorescent and non-fluorescent structures within a synchronized visual field.This eliminates the need for surgeons to toggle between imaging sources mid-procedure, significantly improving workflow efficiency, safety, and surgical precision.

Global Market Footprint

To date, the Toumai® Surgical Robot has obtained market access in more than 60 countries and regions, achieved commercial adoption in over 40, and supported more than 15,000 surgical procedures, including nearly 700 remote telesurgeries across 20+ countries.

It remains the world’s only surgical robot platform compatible with 5G, high- and low-orbit satellites, and broadband networks, enabling real-time telesurgery across long distances and diverse network environments.

The addition of the CE-certified fluorescence system further strengthens Toumai’s global product ecosystem, driving its mission to make surgery safer, smarter, and more accessible worldwide.

Original Story

November 15, 2025, MedChina